About Higlance Laboratories Private Limited
Data last updated:
Higlance Laboratories Private Limited is a private limited company based in New, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 June 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2003PTC120847. Its GSTIN is 07AABCH2836H1ZQ (Delhi). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹6 Cr and a paid-up capital of ₹6 Cr. It is led by directors including Sanjay Kumar Singh (Managing Director) and Ajay Singh (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 1204 Hemkunt Chambers 89 Nehru Place, New, Delhi, India – 110019.
As per the financials filed for FY 2025, the company reported a revenue of ₹75.98 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹6.26 Cr (net margin 8.2%) and EBITDA of ₹11.94 Cr (EBITDA margin 15.7%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 11% over five years.
The company has about 386 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: HiGlance Laboratories and HiGlance. As per MCA filings, the company has open charges of ₹1.86 Cr on record. Court records list 4 cases involving the company, including 3 filed against it; 1 case is pending. The company has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹7.99 Cr; the latest was in September 2011. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Vapi Care Pharma Private Limited. The company has 4 MSME Form 1 returns on record between 2019 and 2024, listing 31 overdue payments to 6 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website higlance.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address1204 Hemkunt Chambers 89 Nehru Place, New, Delhi, India – 110019
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Higlance Laboratories Private Limited
The main business activity of Higlance Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Higlance Laboratories Private Limited FY 2024 filings available
Higlance Laboratories Private Limited reported revenue of ₹75.98 Cr (up 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Higlance Laboratories Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 7% growth in the latest year. EBITDA rose 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Higlance Laboratories Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹11.94 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹6.26 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Higlance Laboratories Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 8.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Higlance Laboratories are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Higlance Laboratories Private Limited
Higlance Laboratories Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Revenue, net profit, margin and growth of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vapi Care Pharma Private Limited | •••• | •••• | •••• | •••• | 109 | Vapi, Valsad, Gujarat, India |
| Aritex Industries Private Limited | •••• | •••• | •••• | •••• | - | Ludhiana, Punjab, India |
| Eskag Pharma Pvt Ltd | •••• | •••• | •••• | •••• | 654 | Kolkata, West Bengal, India |
| Mercury Laboratories Limited Listed | •••• | •••• | •••• | •••• | 472 | Mumbai, Maharashtra, India |
| Vovantis Laboratories Private Limited | •••• | •••• | •••• | •••• | 157 | Vadodara, Gujarat, India |
| Higlance Laboratories Private Limited this company | •••• | •••• | •••• | •••• | - | New Delhi, Delhi, India |
| Vital Therapeutics and Formulations Private Limited | •••• | •••• | •••• | •••• | - | Hyderabad, Telangana, India |
| Bennet Pharmaceuticals Limited | •••• | •••• | •••• | •••• | - | Vadodara, Gujarat, India |
| Rusoma Laboratories Private Limited | •••• | •••• | •••• | •••• | 128 | Mumbai, Maharashtra, India |
| Asmoh Laboratories Limited | •••• | •••• | •••• | •••• | - | New Delhi, Delhi, India |
| Mccoy Pharma Private Limited | •••• | •••• | •••• | •••• | - | Boisar, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Higlance Laboratories by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.
Auditor Details of Higlance Laboratories Private Limited
Higlance Laboratories Private Limited is audited by Naveen Jain & Co. for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Naveen Jain & Co. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Higlance Laboratories Private Limited
Higlance Laboratories has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kalawati Devi | Director | 11 Jun 2003 | 23 Years 3 Months | Current |
| Ajay Singh | Whole-Time Director | 11 Jun 2003 | 23 Years 3 Months | Current |
| Sanjay Kumar Singh | Managing Director | 11 Jun 2003 | 23 Years 3 Months | Current |
Ownership and Shareholding of Higlance Laboratories Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Higlance Laboratories Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Oct 2006 | State Bank of India | ₹1.86 Cr | Open |
Total charge records: 1 View all charges
Deals & Funding of Higlance Laboratories Private Limited
Higlance Laboratories Private Limited has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹7.99 Cr; the latest was in September 2011.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2011 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2011 | Funding round | ₹3 Cr | Investors: an individual |
| Nov 2006 | Funding round | ₹4.99 Cr | Investors: an individual |
Full deal history
All 3 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Higlance Laboratories Private Limited
Higlance Laboratories Private Limited has 4 court cases on record: 3 filed against it, 1 where it is another party. 1 case is pending and 3 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 3 | 1 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (COMIP) | Filed against the company by Glenmark Pharmaceuticals Limited | Pending |
| Bombay High Court | Court case (LPETN) | Filed against the company by Glenmark Pharmaceuticals Limited | Disposed |
| Bombay High Court | Court case (S) | Company is another party | Disposed |
| High Court of Delhi | Court case (CS(OS)) | Filed against the company by an individual | Disposed |
Full case history
All 4 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Higlance Laboratories Private Limited
Higlance Laboratories Private Limited has 4 MSME Form 1 returns on record between 2019 and 2024, listing 31 overdue payments to 6 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 6)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Kambert Machinery Company Private Limited | •••• | •••• | •••• |
| Om Distributors | •••• | •••• | •••• |
| Premier Drug House | •••• | •••• | •••• |
| Electrolab (India) Private Limited | •••• | •••• | •••• |
| S K Pharma Machinery Private Limited | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 4 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Higlance Laboratories Private Limited
Higlance Laboratories operates two associated brands: HiGlance Laboratories and HiGlance. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures pharmaceutical, vitamins, and nutrient products for health-conscious consumers and markets. | higlance.com | |
| Pharmaceutical production and export of medicines for various health issues from India. | higlance.ru |
Employees and EPFO Compliance at Higlance Laboratories Private Limited
Higlance Laboratories Private Limited has a workforce of 386 employees as of Mar 10, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Higlance Laboratories Private Limited
Higlance Laboratories Private Limited has 7 board changes on record since 2003: 3 appointments and 4 cessations. The latest: Anishrava Agrawal ceased to be Company Secretary on 31 May 2024.
Credit Ratings, Litigation & Regulatory Alerts for Higlance Laboratories Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Higlance Laboratories Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Higlance Laboratories Private Limited
Higlance Laboratories has 3 GST registrations: 3 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AABCH2836H1ZQ | Delhi | Active | 01 Jul 2017 |
| 09AABCH2836H1ZM | Uttar Pradesh | Active | 01 Jul 2017 |
| 10AABCH2836H1Z3 | Bihar | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Higlance Laboratories Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Higlance Laboratories Private Limited
Higlance Laboratories is an active private limited company based in New, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 June 2003 (23+ years old) and is registered under CIN U24239DL2003PTC120847.
Higlance Laboratories reported revenue of ₹75.98 Cr for FY 2025 (up 7% YoY).
Higlance Laboratories has 3 current directors:
- Sanjay Kumar Singh - Managing Director
- Ajay Singh - Whole-Time Director
- Kalawati Devi - Director
Higlance Laboratories reported a net profit of ₹6.26 Cr (net margin 8.2%) and EBITDA of ₹11.94 Cr (EBITDA margin 15.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Higlance Laboratories is 8% over three years and 11% over five years. In the latest year (FY 2025) revenue rose 7%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Higlance Laboratories is 07AABCH2836H1ZQ, registered in Delhi. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 09AABCH2836H1ZM (Uttar Pradesh), 10AABCH2836H1Z3 (Bihar).
The CIN (Corporate Identification Number) of Higlance Laboratories is U24239DL2003PTC120847. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Higlance Laboratories has 4 court cases on record: 3 filed against it. 1 is pending.
Higlance Laboratories was incorporated on 11 June 2003, making it 23+ years old. It is registered with the Registrar of Companies, Delhi.
Higlance Laboratories has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹7.99 Cr; the latest was in September 2011.
The peers of Higlance Laboratories by revenue are Vapi Care Pharma Private Limited, Aritex Industries Private Limited, Eskag Pharma Pvt Ltd, Mercury Laboratories Limited, Vovantis Laboratories Private Limited and 5 more, all in the Pharma industry (Formulations).
Anishrava Agrawal ceased to be Company Secretary on 31 May 2024. Ajay Singh ceased to be Director on 10 Mar 2018. Sanjay Kumar Singh ceased to be Director on 10 Mar 2018. Higlance Laboratories has 7 board changes on record in total.